Comparing Obesity Treatments: Terzepatide vs. Semaglutide

This chapter contrasts the effectiveness of terzepatide and semaglutide for weight loss in individuals without type 2 diabetes, looking at trial results on weight loss and blood sugar improvements. It also explores cardiovascular benefits and safety profiles, emphasizing the implications for obesity management and overall health.